Herpes simplex virus is among the most successful neurotropic pathogens in humans, capable of breaching neural defenses, traveling deep into the nervous system, and hiding there for a lifetime. The virus enters cells through a coordinated interaction between its surface glycoproteins and specific human receptors, then hijacks the cell’s own transport machinery to ride along nerve fibers into sensory ganglia and, in some cases, into the brain itself. Most infections stay dormant in peripheral nerve clusters, but when the virus reaches the central nervous system, the consequences can range from recurrent meningitis to devastating encephalitis with lasting cognitive damage.
How the Virus Gets Inside a Cell
HSV does not simply punch through the cell membrane. Entry requires a choreographed sequence involving four viral glycoproteins: gD, gB, and the gH/gL complex. The process begins when glycoprotein D (gD) on the viral surface locks onto one of two structurally unrelated receptors on the target cell: nectin-1 or HVEM (herpesvirus entry mediator).1PLoS Pathogens. Structure of Herpes Simplex Virus Glycoprotein D Bound to the Human Receptor Nectin-1 That initial binding event triggers a cascade of shape changes in the other glycoproteins, ultimately causing the viral envelope to fuse with the host cell membrane. Without gD making contact with one of those receptors, the rest of the entry machinery never activates.2PubMed. Effects of linker-insertion mutations in herpes simplex virus 1 gD on glycoprotein-induced fusion with cells expressing HVEM or nectin-1
Nectin-1 is abundant on neurons and epithelial cells, which partly explains why HSV is so adept at infecting both skin and nerve tissue. HVEM, by contrast, is widely expressed on immune cells. The fact that the virus has two structurally different receptor options makes it unusually versatile: even if one receptor is scarce in a particular tissue, the other may be available. Once the membranes fuse, the viral capsid is released into the cell’s interior, and the real journey toward the nervous system begins.
Riding the Nerve Fiber to the Nucleus
After entering a peripheral nerve ending, the HSV capsid needs to travel a remarkably long distance. Sensory neurons can extend axons from the skin all the way to ganglia near the spinal cord or brainstem, a trip that might span tens of centimeters. The virus cannot swim. Instead, it commandeers the cell’s own molecular transport system, hitching a ride on structures called microtubules using a motor protein called cytoplasmic dynein.
Experiments that disrupted dynein’s partner complex, dynactin, showed that viral capsids still bound to the cell surface and got inside just fine, but far fewer capsids reached the nucleus. The virus’s ability to enter the cell was unaffected; its ability to travel through the cell was crippled.3PubMed Central. Function of dynein and dynactin in herpes simplex virus capsid transport This tells us that dynein-driven retrograde transport, moving from the nerve ending toward the cell body, is the engine behind HSV’s invasion of the peripheral nervous system. The virus essentially converts a normal cellular delivery service into its personal shuttle.
When HSV reactivates and needs to travel back out toward the skin, it reverses direction and uses anterograde transport along the same microtubule tracks. Researchers have observed that the virus can travel in two configurations: as a naked capsid without its envelope (the “Separate” model) or as a fully enveloped particle inside a membrane vesicle (the “Married” model). In neurons studied by electron microscopy, roughly three-quarters of transported particles were of the Married type, though live fluorescence imaging found more Separate particles, suggesting both modes coexist.4PubMed Central. Anterograde transport of herpes simplex virus capsids in neurons by both separate and married mechanisms The practical takeaway is that the virus has multiple strategies for moving through nerve fibers, which likely contributes to its efficiency during both initial infection and recurrence.
Two Roads Into the Brain
Most HSV infections stay confined to the peripheral nervous system, but in rare cases the virus pushes past sensory ganglia and enters the brain. Research in mouse models has identified two distinct routes of central nervous system invasion. The first runs through the trigeminal ganglion, which connects to the brainstem. The second runs through the olfactory nerve, linking the nasal lining directly to the olfactory bulbs at the base of the brain.
After intranasal infection, virus was detectable in the brain at two separate sites on the same day: the trigeminal root entry zone in the brainstem and the olfactory bulbs.5Journal of the Neurological Sciences. Herpes simplex encephalitis: Immunohistological demonstration of spread of virus via olfactory pathways in mice From the brainstem focus, the virus spread to other brainstem nuclei and, in some animals, to the thalamus and cerebellum. From the olfactory bulbs, it spread through anterior olfactory structures into the temporal lobe, hippocampus, and cingulate cortex. These two routes target different brain regions, which has implications for the pattern of damage seen in human encephalitis.
More recent work has added detail to this picture. Following intranasal inoculation, virus first spread from the surface to deeper layers of the olfactory epithelium, then appeared in brainstem regions innervated by the trigeminal nerve and in cranial nerve nuclei including the vagus and hypoglossal nerves. Certain deeper brain structures, including the locus coeruleus, raphe nucleus, and hypothalamus, also became infected, while the hippocampus and cortex were spared in that particular model.6PubMed Central. Olfactory and trigeminal routes of HSV-1 CNS infection with regional microglial heterogeneity The discrepancy between studies likely reflects differences in inoculation method, viral dose, and mouse strain, but the overarching point holds: HSV-1 has multiple neural highways into the brain, and which structures it reaches depends on which route dominates.
How the Virus Hides for a Lifetime
The defining trick of HSV biology is latency. After the initial infection resolves, the virus does not leave the body. Instead, its DNA persists inside neurons as a circular piece of genetic material that sits in the cell nucleus without integrating into the host’s chromosomes. During this dormant phase, the entire viral genome goes silent except for one region: the latency-associated transcript, or LAT.7PubMed Central. Epigenetic regulation of latent HSV-1 gene expression
The mechanism keeping the virus quiet is epigenetic, meaning it involves chemical modifications to the proteins that package the viral DNA rather than changes to the DNA sequence itself. The LAT region carries chemical marks associated with active gene expression, while the genes needed for viral replication are decorated with marks that keep them shut off. DNA methylation, the modification most commonly associated with gene silencing in human cells, does not appear to play a major role; instead, the virus relies on histone modifications to maintain its silent state.
LAT itself appears to actively suppress viral gene expression in neurons, which in turn affects how often the virus reactivates. Experiments in mice have shown that the LAT RNA represses lytic gene expression in small populations of neurons within the trigeminal ganglion, directly influencing how frequently reactivation occurs and how large the pool of potentially reactivating virus remains.8PLoS Pathogens. The HSV-1 Latency-Associated Transcript Functions to Repress Latent Phase Lytic Gene Expression and Suppress Virus Reactivation from Latently Infected Neurons In other words, the virus has evolved a built-in brake on its own reactivation, presumably because killing too many host neurons would eventually destroy the reservoir it depends on for lifelong persistence.
Why HSV-1 and HSV-2 Prefer Different Neighborhoods
One of the more curious features of HSV biology is the site preference of the two virus types. HSV-1 preferentially reactivates from the trigeminal ganglia to cause cold sores around the mouth, while HSV-2 reactivates more efficiently from lumbosacral ganglia to cause genital herpes. This is not absolute, as either virus can infect either site, but the pattern of recurrence is strikingly type-specific.
Research using quantitative viral DNA measurements found that HSV-1 DNA accumulated more in the lumbar spinal cord while HSV-2 DNA was more abundant in the sacral spinal cord, suggesting that underlying differences in where each virus establishes its densest latent reservoir may drive their different reactivation patterns.9PubMed Central. Herpes simplex virus latency-associated transcript sequence downstream of the promoter influences type-specific reactivation and viral neurotropism The LAT region appears to play a role in this neurotropism. These differences in viral distribution within the spinal cord may also help explain why HSV-1 and HSV-2 produce different patterns of CNS disease when things go wrong.
When the Brain Gets Infected
Herpes simplex encephalitis (HSE) is the most severe neurological consequence of HSV infection and remains the most common cause of sporadic fatal encephalitis in Western countries. In adults, HSE caused by HSV-1 has a striking predilection for the temporal lobes. A clinicopathological study in which brain biopsies were performed found characteristic acute necrotizing encephalitis in the temporal lobe in the large majority of cases.10PubMed. A clinico-pathological study of herpes simplex encephalitis The temporal lobe houses structures critical for memory, language, and emotion, which is why HSE often presents with confusion, personality changes, and difficulty speaking before progressing to seizures and coma.
Diagnosing HSE quickly is critical because antiviral treatment with acyclovir dramatically improves survival when started early. The standard diagnostic approach combines MRI, which shows characteristic swelling and signal abnormality in one or both temporal lobes, with detection of viral DNA in cerebrospinal fluid using PCR. In one prospective study, MRI lesions involving the inner and lower portions of the temporal lobes were seen in all PCR-positive patients except one, while no PCR-negative patient showed that same lesion pattern.11PubMed. Diagnosis of herpes simplex encephalitis by magnetic resonance imaging and polymerase chain reaction assay of cerebrospinal fluid The combination of temporal lobe MRI findings and a positive CSF PCR result provides strong diagnostic confidence without requiring brain biopsy.
The Brain’s Immune Response to HSV
The brain is not defenseless against HSV, but its immune response is unusual compared with the rest of the body. Microglia, the resident immune cells of the CNS, serve as the first line of defense. Upon encountering HSV-1, microglia activate and produce inflammatory signaling molecules that help contain the infection, though excessive inflammation can itself damage nearby neurons.12PubMed Central. Role of Microglia in Herpesvirus-Related Neuroinflammation and Neurodegeneration
The molecular pathway by which microglia detect HSV-1 has been mapped in recent years. Microglia sense viral DNA through a pathway called cGAS-STING, which triggers production of type I interferons, the body’s frontline antiviral proteins. Mice lacking either cGAS or STING were highly susceptible to acute encephalitis. Infected microglia did not just protect themselves; they sent signals that activated antiviral defenses in neurons and primed nearby astrocytes (another type of brain cell) to produce their own interferon through a separate pathway involving TLR3.13PubMed Central. Sensing of HSV-1 by the cGAS-STING pathway in microglia orchestrates antiviral defence in the CNS So microglia act as coordinators, detecting the virus and then orchestrating a multi-cell-type defense.14Journal of Virology. Relative contributions of the cGAS-STING and TLR3 signaling pathways to attenuation of herpes simplex virus 1 replication
This is also where individual genetics enter the picture. Rare mutations in the TLR3 gene have been found in children who developed HSE despite having no other immune deficiency. In one study of 120 patients, about 5% carried rare TLR3 mutations that impaired the receptor’s function, leading to reduced interferon production and increased vulnerability to HSV-1 in the brain.15PubMed Central. TLR3 deficiency in herpes simplex encephalitis: high allelic heterogeneity and recurrence risk Children with mutations in TLR3 and a related gene called UNC93B1 showed a selective inability to produce interferons in response to double-stranded RNA, a viral byproduct, with susceptibility limited to herpes encephalitis rather than broad immune failure.16PubMed. Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans This is a striking finding: it means that HSE in some children is essentially a genetic disease of innate immunity rather than simply bad luck with a common virus.
Long-Term Cognitive Damage After Encephalitis
Even with acyclovir treatment, many HSE survivors face lasting neurological consequences. The pattern of damage reflects the virus’s preference for the temporal lobes and medial temporal structures, including the hippocampus. In a multi-center study comparing encephalitis patients to healthy controls, HSV patients showed the most severe impairment on both anterograde memory (forming new memories) and retrograde memory (recalling past events). In the short term, they also had deficits in executive function, IQ scores, and naming ability, though those particular impairments improved over time. Memory problems, by contrast, persisted.17PLoS ONE. Neuropsychological and psychiatric outcomes in encephalitis: A multi-centre case-control study
The correlation between specific brain damage and specific deficits was clear on imaging: memory impairment tracked with hippocampal and medial temporal damage on MRI, while naming difficulties mapped to left temporal and left frontal abnormalities.18Dementia & Neuropsychologia. Dementia and cognitive impairment in adults as sequels of HSV-1-related encephalitis: a review Patients also reported high rates of depression, anxiety, and fatigue that persisted long after their measurable cognitive scores had improved. This gap between objective test performance and subjective experience is something clinicians increasingly recognize: recovering from HSE involves much more than clearing the virus.
Neonatal HSV and the Developing Brain
HSV infection in newborns is rare but disproportionately dangerous, and the developing brain is especially vulnerable. The vast majority of neonatal infections, roughly 85%, are acquired during delivery. About 5% result from intrauterine transmission, and the remaining 10% from postnatal contact.19PubMed. Neonatal herpes simplex virus infection: From the maternal infection to the child outcome
Neonatal HSV can present in three forms: disease limited to skin, eyes, and mouth; central nervous system disease; or disseminated infection affecting multiple organs. The CNS form is particularly concerning because it can present with vague, nonspecific symptoms such as poor feeding, irritability, or seizures, making early diagnosis a challenge. Case reports illustrate the full spectrum of outcomes: some neonates with CNS involvement recover well with prompt acyclovir treatment, while others develop severe meningoencephalitis with fatal results.20PubMed Central. The Many Faces of Neurological Neonatal Herpes Simplex Virus Infection
Among survivors of neonatal herpes encephalitis, the long-term cognitive impact often exceeds what clinicians initially expect. A follow-up study found that infection had a greater impact on cognitive function, speech, and attention than anticipated, with some children experiencing relapse leading to further deterioration. Social skills were affected to a lesser degree.21PubMed. Neuropsychologic outcomes in children with neonatal herpes encephalitis These children typically require long-term multidisciplinary follow-up to identify and address developmental delays as they emerge.
Mollaret’s Meningitis and Recurrent HSV-2 in the CNS
While HSV-1 is the main culprit in encephalitis, HSV-2 has its own neurological signature: recurrent bouts of meningitis known as Mollaret’s meningitis. This rare condition involves repeated episodes of aseptic meningitis, typically presenting with fever, severe headache, and sensitivity to light. Unlike HSE, which destroys brain tissue, Mollaret’s meningitis usually resolves without lasting neurological damage, though the recurrences themselves can be debilitating. In one documented case, a woman experienced four separate episodes over nearly two decades, each time with HSV-2 detectable in her cerebrospinal fluid. Acyclovir treatment resolved each episode.22PubMed Central. Mollaret’s Meningitis due to Herpes Simplex Virus 2: A Case Report and Review of the Literature The recurrent nature of the disease directly mirrors the virus’s cycle of latency and reactivation in sacral ganglia, with periodic spread to the meninges.
The Alzheimer’s Connection
One of the more provocative lines of HSV research involves its potential role in Alzheimer’s disease. HSV-1 has been found in brain regions affected by Alzheimer’s, and several mechanistic links have been proposed, including chronic neuroinflammation, accumulation of the amyloid-beta protein, and disruption of synaptic function.23PubMed Central. HSV-1 as a Potential Driver of Alzheimer’s Disease
Animal experiments have made this connection more concrete. When transgenic mice predisposed to Alzheimer’s pathology were infected with HSV-1, they showed accelerated amyloid-beta deposition, increased brain inflammation, and worsened cognitive performance. The NLRP3 inflammasome pathway, a key inflammatory circuit, was identified as a critical link: blocking NLRP3 signaling reduced amyloid buildup and improved cognition in infected mice.24PubMed Central. Herpes simplex virus 1 accelerates the progression of Alzheimer’s disease by modulating microglial phagocytosis and activating NLRP3 pathway
There is also an intriguing twist to the amyloid story. Research has shown that amyloid-beta oligomers bind to herpesvirus surface glycoproteins, accelerating amyloid deposition but also trapping the virus in the process. This suggests amyloid-beta may have originally evolved as part of the brain’s innate immune defense against pathogens like HSV-1, and that Alzheimer’s pathology might in some cases represent an immune response gone haywire.25Neuron. Alzheimer’s Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection This is still an active area of investigation, and HSV-1 should not be considered a proven cause of Alzheimer’s. But the evidence is compelling enough that the connection is being taken seriously.
Treatment Limitations and the Promise of Gene Editing
Acyclovir and its relatives remain the standard treatment for HSV infections, including neurological disease. These drugs work by targeting the viral DNA-copying machinery, and they are effective at suppressing active infection. However, they cannot touch latent virus sitting quietly in neurons, which is why HSV infections are lifelong and recurrences remain possible even after treatment. Resistance to acyclovir is uncommon in people with healthy immune systems, generally below 1%, but higher rates occur in immunocompromised patients, particularly those who have received bone marrow transplants. Because all currently approved antivirals for HSV target the same viral enzyme, resistance to one often means resistance to others.26PubMed. Acyclovir resistance in herpes simplex viruses: Prevalence and therapeutic alternatives
The most ambitious attempt to move beyond suppression involves gene editing. Researchers have developed engineered enzymes called meganucleases, delivered into neurons using modified viruses (AAV vectors), that can cut and destroy latent HSV DNA directly. In mouse models, a combination approach using two different meganucleases delivered by multiple AAV types eliminated 90% or more of latent HSV-1 DNA in orofacial infection models, and up to 97% in genital infection models.27Nature Communications. Gene editing for latent herpes simplex virus infection reduces viral load and shedding in vivo These numbers are striking because no other approach has come close to clearing the latent reservoir. The work is still preclinical, but it represents the first realistic path toward actually curing an HSV infection rather than merely managing it.
An Ancient Relationship Between Virus and Host
HSV has been with humans, or human ancestors, for an extraordinarily long time. Evolutionary analysis suggests that HSV-1 diverged alongside the human lineage from other primate herpesviruses in a process of ancient coevolution. HSV-2, by contrast, appears to have jumped into the human lineage from the ancestor of modern chimpanzees roughly 1.6 million years ago, making it one of the oldest known examples of cross-species viral transmission in human evolution.28PubMed Central. Evolutionary Origins of Human Herpes Simplex Viruses 1 and 2 After that cross-species jump, the two viruses appear to have exchanged genetic material through recombination events, further complicating the evolutionary picture.29PubMed Central. Ancient Recombination Events between Human Herpes Simplex Viruses This deep evolutionary history helps explain why HSV is so well adapted to human neurons. The virus has had over a million years to refine its strategies for entry, transport, immune evasion, and latency in the human nervous system, which is part of why developing treatments that truly eliminate it has proven so difficult.